The deal size was increased to $175M in common stock from $100M in common stock. Jefferies, TD Cowen, Piper Sandler and Cantor Fitzgerald acted as joint book running managers for the offering.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DRUG:
- Bright Minds Biosciences Prices Upsized US$175 Million Public Offering and Ends ATM Program
- Bright Minds Biosciences Ends Equity Distribution Deal With Piper Sandler and Cantor
- Bright Minds price target raised to $142 from $82 at Baird
- Bright Minds price target raised to $147 from $72 at BTIG
- Bright Minds Biosciences Launches US$100 Million Public Offering to Fund CNS Drug Pipeline